ID   YOS-B
AC   CVCL_H193
DR   Wikidata; Q54995466
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=1486031;
RX   PubMed=10071072;
CC   Population: Japanese.
CC   Doubling time: 48 hours (PubMed=1486031).
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (PubMed=1486031; PubMed=10071072).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_H194 ! YOS-M
SX   Male
AG   77Y
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 19-12-24; Version: 14
//
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RA   Drexler H.G.;
RT   "The leukemia-lymphoma cell line factsbook.";
RL   (In book) ISBN 9780122219702; pp.1-733; Academic Press; London; United Kingdom (2001).
//
RX   PubMed=1486031; DOI=10.1111/j.1365-2141.1992.tb06461.x;
RA   Yasukawa M., Yanagisawa K., Kohno H., Yakushijin Y., Kondo T.,
RA   Fujita S.;
RT   "Simultaneous establishment of myeloid and B-lymphoid cell lines with
RT   identical chromosome abnormalities from Philadelphia chromosome-positive
RT   chronic myelogenous leukaemia.";
RL   Br. J. Haematol. 82:515-521(1992).
//
RX   PubMed=10071072; DOI=10.1016/S0145-2126(98)00171-4;
RA   Drexler H.G., MacLeod R.A.F., Uphoff C.C.;
RT   "Leukemia cell lines: in vitro models for the study of Philadelphia
RT   chromosome-positive leukemia.";
RL   Leuk. Res. 23:207-215(1999).
//